Skip to main content
ImmuneCited

Curcumin per Chronic Inflammation

A

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

Key Study Findings

Review
Therapeutic potential of curcumin against pancreatitis.
Dose: None vs: None Outcome: curcumin effects on pancreatitis via anti-inflammatory and antioxidant … Effetto: None None

Popolazione: None

Review
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: review of dietary polyphenols in type 2 diabetes mellitus management

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Review
Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: review of NF-kB and M1 macrophages in asthma, COPD, and pulmonary fibrosis

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Review
Curcumin Modulation of the Gut-Brain Axis for Neuroinflammation and Metabolic Disorders Prevention and Treatment.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Key Statistics

10

Studi

5870

Partecipanti

Positive

A

Grado

Referenced Papers

Antioxidants (Basel, Switzerland) 2025 8 citazioni
Voprosy pitaniia 2022 1 citazioni
Biomedicines 2021 228 citazioni
Frontiers in medicine 2021 13 citazioni
Advances in experimental … 2021 6 citazioni
European journal of … 2020 91 citazioni
Current medicinal chemistry 2018 13 citazioni
Current pharmaceutical design 2017 168 citazioni
Molecules (Basel, Switzerland) 2015 539 citazioni
BioFactors (Oxford, England) 2013 288 citazioni
BioFactors (Oxford, England) 2013 167 citazioni
Current drug targets 2006 92 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
500-1,000 mg/day curcuminoids
enhancedabsorption:
150-500 mg/day (phytosome or piperine formulation)

Limite massimo: No established UL; generally well-tolerated up to 8 g/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --

Momento migliore per l'assunzione: With meals containing fat and black pepper (piperine) for enhanced absorption

Safety & Side Effects

Effetti collaterali segnalati

  • Gastrointestinal discomfort (nausea, diarrhea, bloating)
  • Headache
  • Yellow stool discoloration
  • Iron absorption interference at very high doses

Interazioni note

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Diabetes medications (may enhance blood sugar lowering)
  • CYP1A2, CYP3A4, CYP2D6 substrates (may inhibit metabolism)
  • Sulfasalazine and cyclophosphamide (may modify effects)

Livello di assunzione massimo tollerabile: No established UL; generally well-tolerated up to 8 g/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Curcumin help with Chronic Inflammation?
Based on 10 studies with 5,870 participants, there is strong evidence from multiple clinical trials that Curcumin may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Curcumin should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day curcuminoids. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, bloating), Headache, Yellow stool discoloration, Iron absorption interference at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 10 peer-reviewed studies with 5,870 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.